The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 22, 2022
Filed:
Apr. 14, 2022
Applicant:
Aveo Pharmaceuticals, Inc., Boston, MA (US);
Inventors:
Michael P. Bailey, Boston, MA (US);
Michael N. Needle, Boston, MA (US);
Assignee:
AVEO Pharmaceuticals, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4709 (2006.01); A61P 35/00 (2006.01); A61K 31/404 (2006.01); A61K 31/44 (2006.01); A61K 31/4439 (2006.01); A61K 31/4545 (2006.01); A61K 31/47 (2006.01); A61K 31/496 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 9/00 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4709 (2013.01); A61K 9/0053 (2013.01); A61K 31/404 (2013.01); A61K 31/44 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01);
Abstract
Disclosed is a method of treating cancer, e.g., refractory cancer, with tivozanib. The methods disclosed include, for example, administering tivozanib as a second or third-line therapy to subjects suffering from refractory advanced renal cell carcinoma where traditional therapies as well as more recent targeted and immune-oncology therapies have not adequately treated the subject.
Bailey, Michael. (2022). Use of tivozanib to treat subjects with refractory cancer (U.S. Patent No. 11504365). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11504365
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile